Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

201 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Ischemic tolerance and endogenous neuroprotection.
Dirnagl U, Simon RP, Hallenbeck JM. Dirnagl U, et al. Among authors: hallenbeck jm. Trends Neurosci. 2003 May;26(5):248-54. doi: 10.1016/S0166-2236(03)00071-7. Trends Neurosci. 2003. PMID: 12744841 Review.
Development of an ischemic tolerance model in a PC12 cell line.
Hillion JA, Takahashi K, Maric D, Ruetzler C, Barker JL, Hallenbeck JM. Hillion JA, et al. Among authors: hallenbeck jm. J Cereb Blood Flow Metab. 2005 Feb;25(2):154-162. doi: 10.1038/sj.jcbfm.9600003. J Cereb Blood Flow Metab. 2005. PMID: 15647748 Free PMC article.
Immunology of ischemic vascular disease: plaque to attack.
Hallenbeck JM, Hansson GK, Becker KJ. Hallenbeck JM, et al. Trends Immunol. 2005 Oct;26(10):550-6. doi: 10.1016/ Trends Immunol. 2005. PMID: 16109503 Review.
Hypophosphorylation of ribosomal protein S6 is a molecular mechanism underlying ischemic tolerance induced by either hibernation or preconditioning.
Miyake S, Wakita H, Bernstock JD, Castri P, Ruetzler C, Miyake J, Lee YJ, Hallenbeck JM. Miyake S, et al. Among authors: hallenbeck jm. J Neurochem. 2015 Dec;135(5):943-57. doi: 10.1111/jnc.13368. Epub 2015 Oct 22. J Neurochem. 2015. PMID: 26375300 Free PMC article.
SUMO and ischemic tolerance.
Lee YJ, Hallenbeck JM. Lee YJ, et al. Among authors: hallenbeck jm. Neuromolecular Med. 2013 Dec;15(4):771-81. doi: 10.1007/s12017-013-8239-9. Epub 2013 Jun 18. Neuromolecular Med. 2013. PMID: 23775726 Review.
SUMOylation participates in induction of ischemic tolerance.
Lee YJ, Castri P, Bembry J, Maric D, Auh S, Hallenbeck JM. Lee YJ, et al. Among authors: hallenbeck jm. J Neurochem. 2009 Apr;109(1):257-67. doi: 10.1111/j.1471-4159.2009.05957.x. Epub 2009 Feb 5. J Neurochem. 2009. PMID: 19200349 Free PMC article.
TNF-alpha-induced tolerance to ischemic injury involves differential control of NF-kappaB transactivation: the role of NF-kappaB association with p300 adaptor.
Ginis I, Jaiswal R, Klimanis D, Liu J, Greenspon J, Hallenbeck JM. Ginis I, et al. Among authors: hallenbeck jm. J Cereb Blood Flow Metab. 2002 Feb;22(2):142-52. doi: 10.1097/00004647-200202000-00002. J Cereb Blood Flow Metab. 2002. PMID: 11823712
Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of ceramide in brain and in plasma.
Zimmermann C, Ginis I, Furuya K, Klimanis D, Ruetzler C, Spatz M, Hallenbeck JM. Zimmermann C, et al. Among authors: hallenbeck jm. Brain Res. 2001 Mar 23;895(1-2):59-65. doi: 10.1016/s0006-8993(01)02028-5. Brain Res. 2001. PMID: 11259760
Biological networks in ischemic tolerance - rethinking the approach to clinical conditioning.
Anrather J, Hallenbeck JM. Anrather J, et al. Among authors: hallenbeck jm. Transl Stroke Res. 2013 Feb;4(1):114-29. doi: 10.1007/s12975-012-0244-z. Transl Stroke Res. 2013. PMID: 24223074 Free PMC article. Review.
Glucosylceramide synthase activity and ceramide levels are modulated during cerebral ischemia after ischemic preconditioning.
Takahashi K, Ginis I, Nishioka R, Klimanis D, Barone FC, White RF, Chen Y, Hallenbeck JM. Takahashi K, et al. Among authors: hallenbeck jm. J Cereb Blood Flow Metab. 2004 Jun;24(6):623-7. doi: 10.1097/01.WCB.0000119990.06999.A9. J Cereb Blood Flow Metab. 2004. PMID: 15181369
201 results
Jump to page